Journals / Acta Orthopaedica et Traumatologica Turcica / 2019 / Cilt: 53 - Sayı: 6

Locally administrated single-dose teriparatide affects critical-size rabbit calvarial defects: A histological, histomorphometric and micro-CT study

Pages
478–484
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study, rhPTH, which is used locally in defect areas to be repaired with bone grafts, increases both new bone volume and total bone volume.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to evaluate the effect of teriparatide (PTH 1-34, rhPTH) on a rabbit defect model with local xenogen grafts histomorphometrically and radiologically.
📊
Key Findings & Data:Methods: For this purpose, two 10 mm diameter critical-size defects were created in the calvaria of 16 rabbits.
💡
Conclusion & Impact:Conclusion: In this study, rhPTH, which is used locally in defect areas to be repaired with bone grafts, increases both new bone volume and total bone volume.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study was to evaluate the effect of teriparatide (PTH 1-34, rhPTH) on a rabbit defect model with local xenogen grafts histomorphometrically and radiologically. Methods: For this purpose, two 10 mm diameter critical-size defects were created in the calvaria of 16 rabbits. In the control group, the defect area was filled with a xenogen graft, while in the teriparatide group (PTH 1-34), a xenogen graft combination with 20 mcg teriparatide was used. For both 4 e week and 8 e week study groups, new bone, residual graft, and soft tissue areas were evaluated as well as bone volume histomorphometrically and radiologically. Results: Histomorphometrically, there was a significant difference in new bone area values at the 8th week (p 0.05). There was no statistically significant difference between the groups at both 4 and 8 weeks (p > 0.05). In the radiologically measured total bone volume values, PTH1-34 group values were found to be significantly higher for both 4 e and 8 e weeks values compared to the control groups (p < 0.05). Conclusion: In this study, rhPTH, which is used locally in defect areas to be repaired with bone grafts, increases both new bone volume and total bone volume.

🔖

Cite This Article

ÖZER, T., BAŞLARLI, Ö., AKTAŞ, A., BARIŞ, E., ÇELİK, H. H., OCAK, M. (2019). Locally administrated single-dose teriparatide affects critical-size rabbit calvarial defects: A histological, histomorphometric and micro-CT study. Acta Orthopaedica et Traumatologica Turcica, Cilt: 53 - Sayı: 6, 478–484. https://ajindex.com/articles/149690

References (15)

  1. Giannoudis P, Psarakis S, Kontakis G. Can we accelerate fracture healing? A critical analysis of the literature. Injury. 2007;38(1):S81eS89
  2. Bezerra BT, Pinho JNA, Figueiredo FED, Brandao J, Ayres LCG, da Silva LCF. Autogenous bone graft versus bovine bone graft in association with plateletrich plasma for the reconstruction of alveolar clefts: a pilot study. Cleft Palate Craniofac J. 2019;56(1):134e140
  3. Aggarwal P, Zavras A. Parathyroid hormone and its effects on dental tissues. Oral Dis. 2012;18(1):48e54
  4. Li YF, Li XD, Bao CY, Chen QM, Zhang H, Hu J. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Osteoporos Int. 2013;24(3): 1063e1071
  5. Tokunaga K, Seto H, Ohba H, et al. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis. J Periodontal Res. 2011;46(6):655e662
  6. Cosman F. Parathyroid hormone treatment for osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2008;15(6):495e501
  7. Skripitz R, Aspenberg P. Parathyroid hormoneea drug for orthopedic surgery? Acta Orthop Scand. 2004;75(6):654e662
  8. Auersvald CM, Santos FR, Nakano MM. The local administration of parathyroid hormone encourages the healing of bone defects in the rat calvaria: microcomputed tomography, histological and histomorphometric evaluation. Arch Oral Biol. 2017;79(1):14e19
  9. Marx J. Coming to grips with bone loss. Science. 2004;305(5689):1420e1422
  10. Deal C, Gideon J. Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis. Cleve Clin J Med. 2003;70(7):585e586, 589e590, 592e4 passim
  11. Ghiasi MS, Chen J, Vaziri A, Rodriguez EK, Nazarian A. Bone fracture healing in mechanobiological modeling: a review of principles and methods. Bone Rep. 2017;6(1):87e100
  12. Pripatnanont P, Nuntanaranont T, Vongvatcharanon S. Proportion of deproteinized bovine bone and autogenous bone affects bone formation in the treatment of calvarial defects in rabbits. Int J Oral Maxillofac Surg. 2009;38(4): 356e362
  13. Pripatnanont P, Nuntanaranont T, Vongvatcharanon S, Phurisat K. The primacy of platelet-rich fibrin on bone regeneration of various grafts in rabbit's calvarial defects. J Craniomaxillofac Surg. 2013;41(8):e191ee200
  14. Tsunori K. Effects of parathyroid hormone dosage and schedule on bone regeneration. J Oral Sci. 2015;57(2):131e136
  15. Tsunori K, Sato S, Hasuike A, et al. Effects of intermittent